Consideration of cardiac function improvement effect of Omega-3 fatty acids(EPA +DHA)
Not Applicable
- Conditions
- Chronic heart failure patient with dyslipidemia
- Registration Number
- JPRN-UMIN000017867
- Lead Sponsor
- Kyorin University School of Medicine, Second department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who are bleeding 2. Past medical history of hypersensitivity 3. Judged as ineligible by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method VEF, E/e', NTproBNP at 0, 6months after starting of treatment
- Secondary Outcome Measures
Name Time Method TG,High sensitivity CRP, Quadrant blood fatty acid(EPA/AA)